{"count":220751,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=983","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=981","results":[{"created":"2022-02-21T20:15:41.121251+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3750","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ROR2 were set to ","entity_name":"ROR2","entity_type":"gene"},{"created":"2022-02-21T20:14:59.538251+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3749","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ROR2 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"ROR2","entity_type":"gene"},{"created":"2022-02-21T20:14:27.784047+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3748","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASET2 as ready","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:14:27.774355+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3748","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaset2 has been classified as Amber List (Moderate Evidence).","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:14:23.615546+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3748","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASET2 were changed from LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY to Leukoencephalopathy, cystic, without megalencephaly MIM#612951","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:14:06.717233+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3747","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASET2 were set to ","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:13:42.285944+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3746","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: RNASET2 as Amber List (moderate evidence)","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:13:42.271735+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3746","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaset2 has been classified as Amber List (Moderate Evidence).","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:13:16.789283+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11044","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASET2 as ready","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:13:16.779868+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11044","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaset2 has been classified as Green List (High Evidence).","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:13:08.217832+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11044","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASET2 were changed from  to Leukoencephalopathy, cystic, without megalencephaly MIM#612951","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:12:47.041603+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11043","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASET2 were set to ","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:12:26.520459+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11042","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RNASET2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASET2","entity_type":"gene"},{"created":"2022-02-21T20:11:46.427053+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11041","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: C17orf53 as ready","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:11:46.417989+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11041","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c17orf53 has been classified as Amber List (Moderate Evidence).","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:11:19.614250+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11041","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: C17orf53 as Amber List (moderate evidence)","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:11:19.602490+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11041","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c17orf53 has been classified as Amber List (Moderate Evidence).","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:11:02.206730+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11040","user_name":"Zornitza Stark","item_type":"entity","text":"gene: C17orf53 was added\ngene: C17orf53 was added to Mendeliome. Sources: Expert Review\nMode of inheritance for gene: C17orf53 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: C17orf53 were set to 34707299; 31467087\nPhenotypes for gene: C17orf53 were set to Primary ovarian insufficiency\nReview for gene: C17orf53 was set to AMBER\nAdded comment: PMID: 34707299. Homozygous LOF variant in individual with primary ovarian insufficiency PMID: 31467087. Mice with targeted mutations in Hrob are infertile due to depletion of germ cells. \nSources: Expert Review","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:09:13.802125+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.287","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: C17orf53 as ready","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:09:13.790826+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.287","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c17orf53 has been classified as Amber List (Moderate Evidence).","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:08:40.107875+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.287","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: C17orf53 as Amber List (moderate evidence)","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:08:40.096512+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.287","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c17orf53 has been classified as Amber List (Moderate Evidence).","entity_name":"C17orf53","entity_type":"gene"},{"created":"2022-02-21T20:08:16.097975+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3745","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2C as ready","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2022-02-21T20:08:16.080387+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3745","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2c has been classified as Green List (High Evidence).","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2022-02-21T20:08:12.154349+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3745","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2C were changed from AICARDI-GOUTIERES SYNDROME 3 to Aicardi-Goutieres syndrome 3 (MIM# 610329), AR","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2022-02-21T20:07:58.228708+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3744","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASEH2C were set to ","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2022-02-21T20:06:48.694989+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.700","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TFAM were set to 27448789; 29021295; 9500544","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:06:20.030599+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.699","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TFAM as Green List (high evidence)","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:06:20.007682+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.699","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfam has been classified as Green List (High Evidence).","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:06:16.350705+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11039","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TFAM were changed from Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)\tMIM#617156 to Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)\tMIM#617156; Perrault syndrome","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:05:37.320509+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.699","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TFAM as Green List (high evidence)","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:05:37.310005+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.699","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfam has been classified as Green List (High Evidence).","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:05:29.054050+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11038","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TFAM were set to 27448789; 29021295; 9500544","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:05:04.628108+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11037","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TFAM as Green List (high evidence)","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:05:04.618983+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11037","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfam has been classified as Green List (High Evidence).","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:04:47.028303+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.11036","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: TFAM: Added comment: PMID: 32399598. Homozygous missense variant predicted pathogenic in patient presenting with Perrault syndrome and intellectual disability\r\n\r\nPMID: 34647195. Same homozygous missense variant in two sisters with premature ovarian insufficiency +/- seizures and their brother with seizures + intellectual disability. Patient fibroblasts have mtDNA depletion\r\n\r\nPMID: 34647195. Zebrafish model with in-frame deletion has ovarian dysgenesis and mtDNA depletion; Changed rating: GREEN; Changed publications: 27448789, 29021295, 9500544, 32399598, 34647195, 34647195; Changed phenotypes: Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) MIM#617156, Perrault syndrome","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T20:04:01.239485+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.698","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TFAM: Rating: GREEN; Mode of pathogenicity: None; Publications: 32399598, 34647195, 34647195; Phenotypes: Perrault syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:56.104826+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.286","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TFAM as ready","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:56.093001+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.286","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfam has been classified as Green List (High Evidence).","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:53.924583+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.286","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TFAM were changed from  to Perrault syndrome; primary ovarian insufficiency +/- seizures/intellectual disability/hearing loss","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:46.366267+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.285","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TFAM were set to PMID: 34647195","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:35.745914+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.284","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TFAM as Green List (high evidence)","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:54:35.734401+11:00","panel_name":"Primary Ovarian Insufficiency_Premature Ovarian Failure","panel_id":3166,"panel_version":"0.284","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfam has been classified as Green List (High Evidence).","entity_name":"TFAM","entity_type":"gene"},{"created":"2022-02-21T18:53:44.123148+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3743","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NKX2-1 as ready","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:53:44.112346+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3743","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nkx2-1 has been classified as Amber List (Moderate Evidence).","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:53:38.900646+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3743","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NKX2-1 as Amber List (moderate evidence)","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:53:38.889327+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3743","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nkx2-1 has been classified as Amber List (Moderate Evidence).","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:53:26.559639+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: NKX2-1: Changed rating: AMBER","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:53:07.957795+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NKX2-1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-02-21T18:52:09.764679+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IYD as ready","entity_name":"IYD","entity_type":"gene"},{"created":"2022-02-21T18:52:09.753183+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: iyd has been classified as Red List (Low Evidence).","entity_name":"IYD","entity_type":"gene"},{"created":"2022-02-21T18:52:04.038445+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IYD as Red List (low evidence)","entity_name":"IYD","entity_type":"gene"},{"created":"2022-02-21T18:52:04.020054+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3742","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: iyd has been classified as Red List (Low Evidence).","entity_name":"IYD","entity_type":"gene"},{"created":"2022-02-21T18:51:47.829707+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3741","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IYD: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"IYD","entity_type":"gene"},{"created":"2022-02-21T18:51:16.461433+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3741","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IRS4 as ready","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:51:16.449730+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3741","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: irs4 has been classified as Red List (Low Evidence).","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:51:10.463428+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3741","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IRS4 as Red List (low evidence)","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:51:10.450116+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3741","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: irs4 has been classified as Red List (Low Evidence).","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:50:59.004137+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: IRS4: Changed rating: RED","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:50:52.192540+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IRS4: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"IRS4","entity_type":"gene"},{"created":"2022-02-21T18:50:22.680145+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DUOXA2 as ready","entity_name":"DUOXA2","entity_type":"gene"},{"created":"2022-02-21T18:50:22.670324+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duoxa2 has been classified as Red List (Low Evidence).","entity_name":"DUOXA2","entity_type":"gene"},{"created":"2022-02-21T18:50:17.788173+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DUOXA2 as Red List (low evidence)","entity_name":"DUOXA2","entity_type":"gene"},{"created":"2022-02-21T18:50:17.776304+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3740","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duoxa2 has been classified as Red List (Low Evidence).","entity_name":"DUOXA2","entity_type":"gene"},{"created":"2022-02-21T18:50:06.675799+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3739","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DUOXA2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"DUOXA2","entity_type":"gene"},{"created":"2022-02-21T18:49:38.993014+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3739","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DUOXA1 as ready","entity_name":"DUOXA1","entity_type":"gene"},{"created":"2022-02-21T18:49:38.981494+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3739","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duoxa1 has been classified as Red List (Low Evidence).","entity_name":"DUOXA1","entity_type":"gene"},{"created":"2022-02-21T18:49:32.458070+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3739","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DUOXA1 as Red List (low evidence)","entity_name":"DUOXA1","entity_type":"gene"},{"created":"2022-02-21T18:49:32.447651+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3739","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duoxa1 has been classified as Red List (Low Evidence).","entity_name":"DUOXA1","entity_type":"gene"},{"created":"2022-02-21T18:49:21.391080+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3738","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DUOXA1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"DUOXA1","entity_type":"gene"},{"created":"2022-02-21T18:48:11.228659+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3738","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DUOX2 as ready","entity_name":"DUOX2","entity_type":"gene"},{"created":"2022-02-21T18:48:11.213425+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3738","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duox2 has been classified as Red List (Low Evidence).","entity_name":"DUOX2","entity_type":"gene"},{"created":"2022-02-21T18:48:05.371879+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3738","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DUOX2 as Red List (low evidence)","entity_name":"DUOX2","entity_type":"gene"},{"created":"2022-02-21T18:48:05.358578+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3738","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duox2 has been classified as Red List (Low Evidence).","entity_name":"DUOX2","entity_type":"gene"},{"created":"2022-02-21T18:47:54.042770+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3737","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DUOX2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"DUOX2","entity_type":"gene"},{"created":"2022-02-21T18:47:27.096438+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3737","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DUOX1 as ready","entity_name":"DUOX1","entity_type":"gene"},{"created":"2022-02-21T18:47:27.086975+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3737","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duox1 has been classified as Red List (Low Evidence).","entity_name":"DUOX1","entity_type":"gene"},{"created":"2022-02-21T18:47:21.825179+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3737","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DUOX1 as Red List (low evidence)","entity_name":"DUOX1","entity_type":"gene"},{"created":"2022-02-21T18:47:21.810214+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3737","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: duox1 has been classified as Red List (Low Evidence).","entity_name":"DUOX1","entity_type":"gene"},{"created":"2022-02-21T18:47:08.856979+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3736","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DUOX1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"DUOX1","entity_type":"gene"},{"created":"2022-02-21T18:46:29.621171+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3736","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2B as ready","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2022-02-21T18:46:29.611251+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3736","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2b has been classified as Green List (High Evidence).","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2022-02-21T18:46:21.509073+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3736","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2B were changed from AICARDI-GOUTIERES SYNDROME 2 to Aicardi-Goutieres syndrome 2, MIM# 610181","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2022-02-21T18:45:55.088360+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3735","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASEH2B were set to ","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2022-02-21T18:45:31.305878+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3734","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2A as ready","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2022-02-21T18:45:31.294732+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3734","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2a has been classified as Green List (High Evidence).","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2022-02-21T18:45:27.228076+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3734","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2A were changed from AICARDI-GOUTIERES SYNDROME 4 to Aicardi-Goutieres syndrome 4 MIM#610333","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2022-02-21T18:45:15.186719+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3733","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASEH2A were set to ","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2022-02-21T18:44:47.791934+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3732","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDCA8 as ready","entity_name":"CDCA8","entity_type":"gene"},{"created":"2022-02-21T18:44:47.782047+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3732","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdca8 has been classified as Red List (Low Evidence).","entity_name":"CDCA8","entity_type":"gene"},{"created":"2022-02-21T18:44:41.453804+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3732","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDCA8 as Red List (low evidence)","entity_name":"CDCA8","entity_type":"gene"},{"created":"2022-02-21T18:44:41.437501+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3732","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdca8 has been classified as Red List (Low Evidence).","entity_name":"CDCA8","entity_type":"gene"},{"created":"2022-02-21T18:44:29.690713+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3731","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDCA8: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Congenital hypothyroidism, thyroid dysgenesis, no OMIM #; Mode of inheritance: None","entity_name":"CDCA8","entity_type":"gene"},{"created":"2022-02-21T18:43:32.422901+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3731","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPRL3 as ready","entity_name":"NPRL3","entity_type":"gene"},{"created":"2022-02-21T18:43:32.404466+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3731","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nprl3 has been classified as Green List (High Evidence).","entity_name":"NPRL3","entity_type":"gene"},{"created":"2022-02-21T18:43:26.780225+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3731","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NPRL3 as Green List (high evidence)","entity_name":"NPRL3","entity_type":"gene"},{"created":"2022-02-21T18:43:26.768322+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3731","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nprl3 has been classified as Green List (High Evidence).","entity_name":"NPRL3","entity_type":"gene"},{"created":"2022-02-21T18:43:03.660418+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3730","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPRL2 as ready","entity_name":"NPRL2","entity_type":"gene"},{"created":"2022-02-21T18:43:03.647726+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3730","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nprl2 has been classified as Green List (High Evidence).","entity_name":"NPRL2","entity_type":"gene"},{"created":"2022-02-21T18:42:29.707816+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.3730","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NPRL2 as Green List (high evidence)","entity_name":"NPRL2","entity_type":"gene"}]}